Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07184203

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine

Alexandria, Egypt

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Tinea capitis patients with ages ranging from 5 to 18 year

Exclusion criteria

  • Patients with contraindications to itraconazole
  • Patients with associated scalp disease.
  • Patients weighing less than 20 Kg.

Treatment and study plan

Itraconazole (ITZ)

Drug

therapy for tinea capitis orally

Primary outcomes

  1. improvement of tinea capitis

    Time frame: 3 months

    cure of tinea capitis

Study contacts

Contact information is provided by the study sponsor or research team.

Marina K Aioub

CONTACT

[email protected]

00201223805043

Sponsors and collaborators

Lead sponsor

Alexandria University

Other

Registry information

Official study title

Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2025
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.